Editorial

Ns-Park network is a French national clinical research network on Parkinson's disease (PD) and movement disorders gathering researchers and clinicians experts in the field. Since 2010, the network is chaired by Prof. Olivier Rascol (Toulouse) and Prof. Jean-Christophe Corvol (Paris, Pitié Salpêtrière). In 2011, they were joined by Prof. Franck Durif (Clermont-Ferrand), the coordinator of France Stim network (dedicated to deep brain stimulation in movement disorders).

 

Pr   Olivier RASCOL

Résultat de recherche d'images pour "rascol olivier"

CIC   Toulouse

INSERM U825

Laboratoire   de Pharmacologie Clinique

olivier.rascol@univ-tlse3.fr

Pr Jean-Christophe   CORVOL

Résultat de recherche d'images pour "jean christophe corvol"

 

CIC   Pitié-Salpétière

Service de Pharmacologie

APHP

jean-christophe.corvol@psl.aphp.fr

Pr   Franck DURIF

Résultat de recherche d'images pour "franck durif"

 

Coordonnateur   du réseau France-Stim

Service de NeurologieCHU   de Clermont-Ferrand

fdurif@chu-clermontferrand.fr

 

Ns-Park includes the 24 French expert centers for PD designated by the French Ministry of Health in 2012 (16 clinical investigation centers and 8 associated centers). The French Parkinson’s disease genetics network (PDG network) coordinated by Prof. Brice joined Ns-Park network in 2014 strengthening their visibility and allowing a global approach of Parkinson’s disease, both medical, genetic and surgical.

 

Ns-Park network has numerous collaborations with:

  • Preclinical research teams
  • Clinical research infrastructures such as: CATI (center for image acquisition and processing), BioCollection (French biobanking consortium), NeurATRIS (French translational research infrastructure).
  • Patients' associations

The objective of Ns-Park network is to promote clinical research with the aim:

  • To understand cerebral mechanisms underlying  physiological functions such as motor control (physiology),
  • To understand pathophysiological mechanisms underlying the development of movement disorders (motor and non-motor symptoms)
  • To develop innovating therapeutic strategies improving the management of PD and movement disorders.

 

Patients are informed of studies through Ns-Park investigators. Centers of the network are widely distributed in France allowing a large number of patients to participate to studies. A national registry including patients agreeing to participate to studies is available in all centers to facilitate inclusions. Ns-Park network performs only studies fulfilling the legal framework, in compliance with good clinical practices.

 

In 2014, NS PARK has been certified by the French Clinical Research Infrastructue FCRIN, the French counterpart of ECRIN, a pan-European support infrastructure for multinational clinical trials.

The Ns-Park network is thus receives financial support from FCRIN and Inserm.

  

 

We wish you a pleasant visit!

 

The Steering committee

English